
Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg)
Active composition
+2 more active ingredients
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Medical applications
Emsita Trio 10mg/500mg/100mg Tablet ER is a combination medication containing Dapagliflozin, Metformin, and Sitagliptin used to help manage blood glucose levels in individuals with diabetes. Dapagliflozin works by preventing the kidneys from reabsorbing excess glucose, allowing it to be eliminated through urine. Metformin helps reduce the production of glucose in the liver and improves the body’s response to insulin. Sitagliptin works by increasing the levels of incretin hormones that help regulate insulin release after meals. The combined action of these medicines helps maintain stable blood sugar levels and improves overall glycemic control. The extended release formulation allows the medicine to release gradually in the body, providing long lasting effectiveness throughout the day. Maintaining controlled blood sugar levels is important for reducing the risk of diabetes related complications. When used as directed by a healthcare professional along with healthy lifestyle practices, Emsita Trio Tablet ER helps support effective diabetes management and overall metabolic health.
How to use Emsita Trio Tablet ER Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Emsita Trio 10mg/500mg/100mg Tablet ER may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is not known whether it is safe to consume alcohol with Emsita Trio 10mg/500mg/100mg Tablet ER. Please consult your doctor.
High Risk
Information regarding the use of Emsita Trio 10mg/500mg/100mg Tablet ER during pregnancy is not available. Please consult your doctor.
Medical Advice
Emsita Trio 10mg/500mg/100mg Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
There is limited information available on the use of Emsita Trio 10mg/500mg/100mg Tablet ER in patients with liver disease. Please consult your doctor.
Regular Checkup
Information regarding the use of Emsita Trio 10mg/500mg/100mg Tablet ER during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Emsita Trio 10mg/500mg/100mg Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Emsita Trio 10mg/500mg/100mg Tablet ER may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Emsita Trio 10mg/500mg/100mg Tablet ER

Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Medical applications
Emsita Trio 10mg/500mg/100mg Tablet ER is a combination medication containing Dapagliflozin, Metformin, and Sitagliptin used to help manage blood glucose levels in individuals with diabetes. Dapagliflozin works by preventing the kidneys from reabsorbing excess glucose, allowing it to be eliminated through urine. Metformin helps reduce the production of glucose in the liver and improves the body’s response to insulin. Sitagliptin works by increasing the levels of incretin hormones that help regulate insulin release after meals. The combined action of these medicines helps maintain stable blood sugar levels and improves overall glycemic control. The extended release formulation allows the medicine to release gradually in the body, providing long lasting effectiveness throughout the day. Maintaining controlled blood sugar levels is important for reducing the risk of diabetes related complications. When used as directed by a healthcare professional along with healthy lifestyle practices, Emsita Trio Tablet ER helps support effective diabetes management and overall metabolic health.
How to use Emsita Trio Tablet ER Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Emsita Trio 10mg/500mg/100mg Tablet ER may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is not known whether it is safe to consume alcohol with Emsita Trio 10mg/500mg/100mg Tablet ER. Please consult your doctor.
High Risk
Information regarding the use of Emsita Trio 10mg/500mg/100mg Tablet ER during pregnancy is not available. Please consult your doctor.
Medical Advice
Emsita Trio 10mg/500mg/100mg Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
There is limited information available on the use of Emsita Trio 10mg/500mg/100mg Tablet ER in patients with liver disease. Please consult your doctor.
Regular Checkup
Information regarding the use of Emsita Trio 10mg/500mg/100mg Tablet ER during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Emsita Trio 10mg/500mg/100mg Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Emsita Trio 10mg/500mg/100mg Tablet ER may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Emsita Trio 10mg/500mg/100mg Tablet ER













